West Pharmaceutical Services Inc (WST)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$230.00

Buy

$234.55

arrow-up$9.78 (+4.39%)

Prices updated at 01 Mar 2025, 00:38 EST
| Prices minimum 15 mins delay
|
Prices in USD

West Pharmaceutical Services Inc develops, manufactures and sells packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, and prefillable syringe components.

Income statement

20232024
2,950m2,893m
1,129m999m
707m591m
23.9820.42
593m493m
844m744m
Sales, General and administrative353m339m
Interest expenses9m3m
Provision for income taxes122m108m
Operating expenses422m408m
Income before taxes698m586m
Net income available to common shareholders593m493m
7.986.75
Net interest income19m17m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)7.886.69
Free cash flow per share5.56294.3445
Book value/share39.023138.065
Debt equity ratio0.0545990.106028

Balance sheet

20232024
Current assets1,936m1,538m
Current liabilities672m550m
Total capital2,954m2,885m
Total debt309m302m
Total equity2,881m2,682m
Total non current liabilities--
Loans73m203m
Total assets3,830m3,643m
Total liabilities--
Cash and cash equivalents854m485m
Common stock74m72m

Cash flow

20232024
Cash at beginning of period894m854m
Cash dividends paid-57m-59m
415m276m
Investments (gains) losses-369m-379m
854m485m
Net income--
777m653m
-362m-377m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.